MedPath

Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype

Not Applicable
Completed
Conditions
Neurofibromatoses
Interventions
Behavioral: Stress Management Group 2
Behavioral: Stress Management Group 1
Registration Number
NCT02387177
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The aim of this research is to adapt the NF-specific adult version of the Skype 3RP for use with adolescents, and to test its feasibility, acceptability, and preliminary effect in improving quality of life, and in decreasing stress and psychological distress.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria
  1. Must be between the ages of 12 and 17
  2. Can read and speak English at or above the 6th grade level
  3. Diagnosis of neurofibromatosis type 1 or neurofibromatosis type 2 by a specialized medical provider
Exclusion Criteria
  1. Severe active or untreated major mental illness that would interfere with study participation, to be determined at the discretion of the study investigator (e.g. untreated psychosis or suicidality)
  2. Recent (within past 3 months) change in antidepressant medication
  3. Use of formal relaxation training (including past participation in a mind-body program), currently or in the past 6 months
  4. Unable or unwilling to sign the informed consent documents
  5. Unable or unwilling to participate in an intervention delivered via videoconferencing with Skype

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Stress Management Group 2Stress Management Group 2Subjects will attend group stress management sessions via Skype once weekly for 8 weeks and learn stress/NF symptoms managements techniques.
Stress Management Group 1Stress Management Group 1Subjects will attend group stress management sessions via Skype once weekly for 8 weeks and learn stress/NF symptoms managements techniques.
Primary Outcome Measures
NameTimeMethod
Quality of life (WHO-QOLBREFadol)Change between Baseline (week0), Post-intervention (Week8) and Follow Up (Week 36)

Measures quality of life

Secondary Outcome Measures
NameTimeMethod
Generalized Anxiety Disorder 7-item (GAD-7) scaleChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

A brief measure for assessing generalized anxiety disorder

Perceived Stress Scale (PSS-10)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

Situations in one's life over the past month/week are appraised as stressful

Pain Interference Index (PII)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

How much pain has interfered with their life

Measure of Current Status (MOCS) Part AChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

Measures participants' current self-perceived status on several skills that are targeted by the intervention: the ability to relax at will, recognize stress-inducing situations, restructure maladaptive thoughts, be assertive about needs, and choose appropriate coping responses as needed.

The Pain Catastrophizing Scale - Child Version (PCS-C)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

Measures how individuals experience pain

Patient Health Questionnaire for Adolescents (PHQ-A)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

Symptoms of depression and functional impairment

Interpersonal Reactivity Index (IRI)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

Assesses the cognitive and affective dimensions of empathy

Epworth Sleepiness Scale-Revised for Children (ESS)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

Measures how likely one is to doze off or sleep in certain situations

Gratitude Questionnaire Six-Item Form (GQ-6)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

Assesses individual differences in the proneness to experience gratitude in daily life

Child and Adolescent Mindfulness Measure (CAMM)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

Assesses mindfulness in children and adolescents

Life Orientation Test (LOT) Optimism ScaleChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

Individual differences in generalized optimism versus pessimism

Satisfaction with life adolescentChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

measures global satisfaction with life

Functional Assessment of Chronic Illness Therapy- Spiritual Well-Being Scale (FACIT-Sp)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

Spiritual well-being (sense of meaning in life and the sense of strength in one's faith) over the past 7 days

MOS (Support/Empathy)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

Measures recent thinking about the various dimensions of social support.

Quality of Life (WHOQOL-BREF)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

The WHOQOL-BREF comprises of 26 items which measure the following broad domains: physical health, psychological health, social relationships, and environment. The WHOQOL-BREF is a shorter version of the original instrument that may be more convenient for use in large research studies or clinical trials.

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath